🟢 Nuvation Bio is trading 4.13% up today — immediate catalyst unconfirmed

Nuvation Bio is trading at $6.93, up +4.13%, while the immediate catalyst remains unconfirmed.

• No new company-specific announcement, filing, earnings release, or scheduled investor event was identified for September 1, 2026.
• The latest major company news was the FDA Fast Track designation for safusidenib on August 20, 2026.
• The gain is occurring despite weaker broader markets and a 4.24% biotech-sector decline, so it does not clearly track macro or sector performance.